Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/102465
dc.contributor.author | Nayagam, Shevanthi |
---|---|
dc.contributor.author | Thursz, Mark |
dc.contributor.author | Sicuri, Elisa |
dc.contributor.author | Conteh, Lesong |
dc.contributor.author | Wiktor, Stefan |
dc.contributor.author | Low-Beer, Daniel |
dc.contributor.author | Hallett, Timothy B. |
dc.date | 2016-10-07T14:03:33Z |
dc.date | 2016-10-07T14:03:33Z |
dc.date | 2016-09-13 |
dc.date | 2016-10-05T18:01:20Z |
dc.identifier.citation | 1473-3099 |
dc.identifier.uri | http://hdl.handle.net/2445/102465 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1016/S1473-3099(16)30204-3 |
dc.relation | Lancet Infectious Diseases, 2016 |
dc.relation | http://dx.doi.org/10.1016/S1473-3099(16)30204-3 |
dc.rights | cc by (c) Nayagam et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject | Virus de l'hepatitis B |
dc.subject | Vacunes antivíriques |
dc.subject | Hepatitis B virus |
dc.subject | Viral vaccines |
dc.title | Requirements for global elimination of hepatitis B: a modelling study |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |